How to Interpret Relative Risk vs Absolute Risk

Relative risk and absolute risk describe different aspects of the same result. Relative measures often make changes look larger, while absolute measures show how many people are actually affected. In longevity and prevention research, both are necessary for a balanced interpretation. [1] [2] [3]

1. Relative Risk Describes Proportional Change

Relative risk (or risk ratio) compares the probability of an outcome in one group to the probability in another group. A relative risk below 1 suggests lower risk in the exposed or treated group, while a value above 1 suggests higher risk. [1] [4]

Relative measures are useful because they allow comparisons across studies and populations, but they do not tell you how common the outcome is to begin with. [2] [5]

2. Absolute Risk Shows Practical Impact

Absolute risk describes the actual probability of an event. Absolute risk reduction (or increase) reports the difference in event rates between groups. This is often more informative for practical decisions than relative risk alone. [2] [3]

Example: a 20% relative risk reduction may sound large, but if baseline risk falls from 5% to 4%, the absolute risk reduction is 1 percentage point. These are both true, but they communicate different things. [2] [6]

3. Baseline Risk Changes Interpretation

The same relative effect can lead to very different absolute effects depending on baseline risk. This is a major reason readers should ask who was studied and what the underlying event rate was. [2] [5]

In longevity-related studies, baseline risk may differ substantially by age, sex, smoking status, comorbidity burden, and follow-up duration, which can change the practical meaning of the same relative estimate. [2] [7]

4. Confidence Intervals Matter for Both Relative and Absolute Measures

A point estimate is incomplete without a confidence interval. Intervals describe the precision of the estimate and can indicate whether the observed effect is compatible with a range of clinically trivial, moderate, or large effects. [2] [8]

Wide intervals are common in small studies and should lower confidence in strong claims, even when a headline highlights a dramatic relative percentage. [2] [9]

5. Relative Risk Is Not the Same as Odds Ratio

Some studies report odds ratios instead of risk ratios, especially case-control studies and logistic regression models. Odds ratios can overstate perceived effects when outcomes are common, so they should not be casually read as risk ratios. [4] [5]

6. How to Read Risk Claims in Longevity Coverage

• Look for both the relative measure and the absolute event rates.
• Check the baseline risk and population characteristics.
• Read the confidence interval, not only the point estimate.
• Confirm whether the endpoint is mortality, disease incidence, function, or a biomarker.
• Check whether the estimate comes from a trial or an observational study.

This reduces the chance of being misled by a large-sounding percentage that reflects a small absolute change. [2] [3]

Summary

Relative risk is useful for comparing groups, but absolute risk is essential for understanding practical impact. In longevity research, the strongest interpretation comes from reading both measures together, alongside baseline risk, endpoint type, and confidence intervals. [1] [2] [8]

References

1. National Cancer Institute Dictionary: relative risk.
2. Cochrane Handbook for Systematic Reviews of Interventions (Version 6+).
3. National Cancer Institute Dictionary: absolute risk.
4. Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. BMJ (2002).
5. Bland JM, Altman DG. Statistics Notes: The odds ratio. BMJ (1998).
6. CEBM Oxford: Number Needed to Treat (NNT) and absolute effects (EBM tools).
7. Justice JN, et al. Frameworks for proof-of-concept clinical trials of interventions that target fundamental aging processes. Journals of Gerontology A (2018).
8. Guyatt GH, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (2008).
9. Ioannidis JPA. Why Most Published Research Findings Are False. PLoS Medicine (2005).